Jiangsu Run'an Pharmaceutical Co. Ltd. is a wholly-owned subsidiary of Jiangsu Zhengda Qingjiang Pharmaceutical Co., Ltd. It is Zhengda Qingjiang that actively responds to the national call to accelerate the adjustment of industrial structure, realize the extension of the industrial chain, promote the optimization and upgrading of the industry, ensure the safety of the supply of raw materials, and open up the international market. It is an important measure to accelerate the industrialization of new products and carry out long-term strategic planning. The project started construction in November 2018, covering an area of 59 acres, with a total investment of 160 million yuan, and a total construction area of about 25,000 square meters. The first phase mainly constructs a general API production workshop, an anti-tumor API production workshop, a fermentation workshop, and a R&D center.